Chad Winters - 20 Feb 2024 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
VP, Chief Accounting Officer
Signature
/s/ Luis Cantarero
Issuer symbol
WST
Transactions as of
20 Feb 2024
Net transactions value
$0
Form type
4
Filing time
22 Feb 2024, 18:47:10 UTC
Previous filing
21 Dec 2023
Next filing
12 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WST Common Stock Award $0 +179 +14% $0.000000 1,449 20 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Stock Options (Right to Buy) Award $0 +1,020 $0.000000 1,020 20 Feb 2024 Stock Options (Right to Buy) 1,020 $350.18 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 2021 PSUs (PP20) award vesting net of taxes withheld.
F2 This grant vests in four equal installments beginning on February 20, 2025.